Major institutional investors have increased their exposure to neurological disorder treatment companies in 2024 and 2025, ...

Advances such as triple agonists, gene editing, and microbiome therapy offer hope for metabolic diseases, but global access and early detection remain limited.

ADHD diagnosis currently relies on behavioral tests and patient interviews – could biomarkers offer a more accurate and ...

Speech-to-Text API Market is projected to grow from USD 3.2 billion in 2023 to approximately USD 16.1 billion by ...

As part of the MoU, OpenAI is contributing educational content to India’s FutureSkills portal and iGOT Karmayogi training ...